Zymeworks
Michael Lee is a Senior Research Associate at Zymeworks Inc. since September 2022, specializing in Antibody Discovery and Engineering. Prior experience includes roles in Antibody Repertoire Engineering and Screening at Amgen, and as a Molecular Biology Research Affiliate at Agriculture and Agri-Food Canada. Additional positions held include Antibody Generation Research Assistant at Applied Biological Materials and Lab Assistant at the UBC Canadian Center for the Culture of Microorganisms. Michael Lee holds a Master's degree in Biomedical Engineering from the University of Toronto and a Master of Applied Science in Biomedical/Medical Engineering from the Institute of Biomedical Engineering. Michael Lee completed a Bachelor of Science in Biology/Biological Sciences at The University of British Columbia and attended Eric Hamber Secondary School from 2009 to 2014.
Zymeworks
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.